Literature DB >> 25600387

SUPPORT and Comparative Effectiveness Trials: What's at Stake?

Lois Shepherd.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 25600387     DOI： 10.1002/hast.417

Source DB:  PubMed          Journal:  Hastings Cent Rep        ISSN： 0093-0334            Impact factor:   2.683


× No keyword cloud information.
  2 in total

1.  The ethics and regulatory landscape of including vulnerable populations in pragmatic clinical trials.

Authors:  Mary Jane Welch; Rachel Lally; Jennifer E Miller; Stephanie Pittman; Lynda Brodsky; Arthur L Caplan; Gina Uhlenbrauck; Darcy M Louzao; James H Fischer; Benjamin Wilfond
Journal:  Clin Trials       Date:  2015-09-15       Impact factor: 2.486

2.  Incidence and Early Course of Retinopathy of Prematurity: Secondary Analysis of the Postnatal Growth and Retinopathy of Prematurity (G-ROP) Study.

Authors:  Graham E Quinn; Gui-Shuang Ying; Edward F Bell; Pamela K Donohue; David Morrison; Lauren A Tomlinson; Gil Binenbaum
Journal:  JAMA Ophthalmol       Date:  2018-12-01       Impact factor: 7.389
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.